Skip to main content

Research summary

Research Hub

Pinealon

Clinical10 studies

Pinealon is a synthetic tripeptide studied in aging and neuroprotection research for its effects on neuronal signaling pathways.

Being studied for

  • Neuronal aging research
  • Cognitive decline models
  • Cellular stress resistance

Published Research

Evidence profile

Controlled human evidence

10 cited publications · 1 primary trial

Findings below belong to the studies that reported them. They describe the material and conditions those authors used, not this product, and not an outcome to expect.

Supporting evidence

ClinicalPrimary trial

[The peptide correction of neurotic disorders among professional truck-drivers]

Bashkireva AS et al. · Advances in gerontology = Uspekhi gerontologii · 2012

The study reportedThe best effect was obtained in case of combined application of several cytogens (pinealon and vezugen), which were optimally selected regarding the effect of each adverse occupational factor on a target organ or system.

PMID 23734521View on PubMed
Additional indexed literature (9)

Published studies summarised here concern the specific investigational or pharmaceutical materials and study conditions described by their authors. Their findings are not performance claims for Cobalt Peptides material. Citations verified against PubMed on 2026-08-09.

Notice

All information on this page is provided strictly for laboratory research and educational purposes only.